Board

CEO
Sven Rohmann

CEO since 2025. Dr. Sven Rohmann has a long track record in the pharmaceutical and biotechnology industry. As CEO of the Swedish immuno-oncology company Oasmia, he led capital raising for and the launch of Apealea, a pioneering treatment against ovarian cancer. The drug was launched in Sweden, Denmark and Finland at the beginning of 2020 and was subsequently out-licensed to the American company Elevar Therapeutics. Dr. Rohmann was also the founder and CEO of Ganymed Pharmaceuticals, where he took the company’s lead drug candidate IMAB362 from discovery to clinical phase II. Ganymede was later acquired by Astellas. Earlier in his career, he was CEO of BioVision, which under his leadership was acquired by Digilab Inc.

Sven owns no shares in the company. Independent in relation to the company and its senior executives. Independent in relation to major shareholders.

Chairman

Richard Wall

Chairman since 2023. Military cadet training / management, courses in business administration and training in electrical installation. Richard has an education and has been employed in the military in the air force. He has had management functions in the service industry with a total of over 500 employees between 1988 and 1998. He has since worked as Sales Manager at Ahlsell and is the founder of Wallmega AB. He is today CEO of Wallmega AB. He is also a board member of Wall Group AB, Wiam Holding AB and Målerimästarna Stockholm AB.

Richard does not own any shares in the company. Independent in relation to the company and its senior executives. Independent in relation to major shareholders.

Board members

Bo Ziedén

Board member since 2024. Dr Bo Ziedén is a doctor with specialist training in internal medicine and stroke medicine. He has over 30 years of experience in clinical work and conducting and publishing clinical studies with a focus on cardiovascular risks and stroke.

Bo owns no shares in the company. Independent in relation to the company and its senior executives. Independent in relation to major shareholders.

John Brauns

Board member since 2024. Dr John Brauns is a doctor with specialist training in internal medicine. He has over 10 years of experience in clinical work. He has several board assignments in local companies and since 2023 runs the wellness company PRIVO AB, and has previously served 2 terms in the Regional Council in Östergötland.

John does not own any shares in the company. Independent in relation to the company and its senior executives. Independent in relation to major shareholders.